Carlos Gómez-Martín

1 ta ish

Hospital Universitario 12 De Octubre

1. A clinical trial of CTLA-4 blockade with tremelimumab in patients with hepatocellular carcinoma and chronic hepatitis C

   Bruno Sangro, Carlos Gómez-Martín, Manuel de la Mata +11

   Maqola20132 iqtibos

   ABIABI:AkademIndex/2026.other.241866